Valuation: Cegedim

Market Cap 15Cr 17Cr 14Cr 13Cr 24Cr 1.63TCr 24Cr 168.84Cr 66Cr 832.17Cr 64Cr 62Cr 2.68TCr P/E 2026 *
7.13x
P/E 2027 * 5.96x
Enterprise Value 35Cr 40Cr 33Cr 30Cr 57Cr 3.84TCr 57Cr 397.05Cr 154.43Cr 1.96TCr 149.38Cr 146.17Cr 6.29TCr EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.48x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.74%
1 week-3.53%
Current month-3.36%
1 month+5.80%
3 months+5.19%
6 months-13.17%
Current year-19.26%
1 week 10.8
Extreme 10.8
11.28
1 month 10.2
Extreme 10.2
11.82
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
19.6
5 years 8.5
Extreme 8.5
28.9
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Date Insider Type Main position Quantity % Market Cap. Importance
30/04/26 Buy 751 0.0053%
28/04/26 Buy 74,537 0.5287%
16/04/26 Buy 500 0.0035%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-3.53%+3.21%-38.61% 17Cr
+0.78%+4.00%+0.14%+61.74% 3,90000Cr
+1.41%+2.73%+6.98%+1,056.35% 46TCr
+1.61%+5.07%-50.35%+31.66% 43TCr
+3.23%+8.11%+97.53%+240.44% 33TCr
+2.27%+6.14%+124.91%+531.30% 28TCr
+1.92%+1.77%-18.57%+52.64% 24TCr
+1.39%+6.18%-24.43%+23.03% 14TCr
+3.88%+8.70%+121.43%+219.16% 14TCr
+0.66%+3.60%+76.82%+194.65% 9.93TCr
Average +1.50%+3.75%+33.77%+237.23% 60.14TCr
Weighted average by Cap. +1.52%+4.26%+10.89%+171.04%

Financials

2026 *2027 *
Net sales 66Cr 74Cr 62Cr 56Cr 105.74Cr 7.17TCr 106.51Cr 741.92Cr 288.56Cr 3.66TCr 279.12Cr 273.13Cr 12TCr 68Cr 77Cr 64Cr 58Cr 109.42Cr 7.42TCr 110.21Cr 767.73Cr 298.6Cr 3.78TCr 288.83Cr 282.64Cr 12TCr
Net income 2.14Cr 2.42Cr 2.01Cr 1.82Cr 3.44Cr 232.93Cr 3.46Cr 24Cr 9.38Cr 118.83Cr 9.07Cr 8.88Cr 382.01Cr 2.56Cr 2.88Cr 2.39Cr 2.17Cr 4.1Cr 277.64Cr 4.13Cr 29Cr 11Cr 141.63Cr 11Cr 11Cr 455.32Cr
Net Debt 20Cr 23Cr 19Cr 17Cr 33Cr 2.2TCr 33Cr 228.22Cr 89Cr 1.12TCr 86Cr 84Cr 3.62TCr 18Cr 20Cr 17Cr 15Cr 29Cr 1.93TCr 29Cr 200.14Cr 78Cr 986.45Cr 75Cr 74Cr 3.17TCr
Projected Income Statement - Annual - Cegedim
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,487
Date Price Change Volume
06/26/06 €10.94 +0.74% 1,864
05/26/05 €10.86 +0.18% 2,610
02/26/02 €10.84 -1.99% 9,521
01/26/01 €11.06 -2.30% 3,617
30/26/30 €11.32 -0.18% 2,820
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Cegedim
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.94EUR
Average target price
15.13EUR
Spread / Average Target
+38.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cegedim
  1. Stock Market
  2. Stocks
  3. ALCGM Stock